Unknown

Dataset Information

0

Carvedilol as a potential novel agent for the treatment of Alzheimer's disease.

ABSTRACT: Oligomeric ?-amyloid (A?) has recently been linked to synaptic plasticity deficits, which play a major role in progressive cognitive decline in Alzheimer's disease (AD). Here we present evidence that chronic oral administration of carvedilol, a nonselective ?-adrenergic receptor blocker, significantly attenuates brain oligomeric ?-amyloid content and cognitive deterioration in 2 independent AD mouse models. We found that carvedilol treatment significantly improved neuronal transmission, and that this improvement was associated with the maintenance of number of the less stable "learning" thin spines in the brains of AD mice. Our novel observation that carvedilol interferes with the neuropathologic, biochemical, and electrophysiological mechanisms underlying cognitive deterioration in AD supports the potential development of carvedilol as a treatment for AD.

SUBMITTER: Wang J 

PROVIDER: S-EPMC2966505 | biostudies-literature | 2011 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Oligomeric β-amyloid (Aβ) has recently been linked to synaptic plasticity deficits, which play a major role in progressive cognitive decline in Alzheimer's disease (AD). Here we present evidence that chronic oral administration of carvedilol, a nonselective β-adrenergic receptor blocker, significantly attenuates brain oligomeric β-amyloid content and cognitive deterioration in 2 independent AD mouse models. We found that carvedilol treatment significantly improved neuronal transmission, and that  ...[more]

Similar Datasets

Unknown R-carvedilol, a potential new therapy for Alzheimer's disease.
| S-EPMC9756136 | biostudies-literature
Unknown Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease.
| S-EPMC4964411 | biostudies-literature
Unknown Latrepirdine, a potential novel treatment for Alzheimer's disease and Huntington's chorea.
| S-EPMC3346261 | biostudies-literature
Unknown Novel Benzothiazole-based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer's Disease Treatment.
| S-EPMC6696238 | biostudies-literature
Unknown Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer's Disease.
| S-EPMC9313321 | biostudies-literature
Unknown Novel Donepezil-Arylsulfonamide Hybrids as Multitarget-Directed Ligands for Potential Treatment of Alzheimer's Disease.
| S-EPMC8002323 | biostudies-literature
Unknown Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
| S-EPMC6412560 | biostudies-literature
Unknown Aaptamine - a dual acetyl - and butyrylcholinesterase inhibitor as potential anti-Alzheimer's disease agent.
| S-EPMC9380430 | biostudies-literature
Unknown Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer's Disease Treatment through Rigidification Strategy.
| S-EPMC8123621 | biostudies-literature
Unknown Therapeutic Potential of Targeting Mitochondria for Alzheimer's Disease Treatment.
| S-EPMC9697019 | biostudies-literature